Fundamental Review for Rockwell Medical Technologies, Inc.

0 Comments | M2 Presswire, May, 2007

M2 PRESSWIRE-11 May 2007-Biotech News: Fundamental Review for Rockwell Medical Technologies, Inc.(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:11052007 Rockwell Medical Technologies keeps on trucking with its hemodialysis products. The company makes hemodialysis concentrates (in liquid and dry powder form), dialysis kits, and other related products for treatment of end-stage renal disease (permanent kidney failure).

Subsidiary Rockwell Transportation delivers supplies to customers in 35 US states via its own truck fleet. The company markets and distributes its products directly to hemodialysis providers across the US, as well as through independent distributors abroad. CEO Robert L. Chioini owns about 18 of the company. Shares were down 10 reporting record Q1....

Read the rest of this article with a Free Trial at HighBeam Research.
Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:
  1. You are currently: a Guest |
  4.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)